CVS — CVS Health Income Statement
0.000.00%
Last trade - 00:00
- $98.76bn
- $149.09bn
- $357.78bn
- 78
- 89
- 75
- 95
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 256,776 | 268,706 | 292,111 | 322,467 | 357,776 |
Cost of Revenue | |||||
Gross Profit | 45,528 | 49,046 | 52,120 | 54,502 | 54,431 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 244,868 | 256,235 | 279,253 | 314,513 | 344,033 |
Operating Profit | 11,908 | 12,471 | 12,858 | 7,954 | 13,743 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8,997 | 9,770 | 10,537 | 5,836 | 11,173 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6,631 | 7,201 | 7,989 | 4,327 | 8,368 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 6,634 | 7,179 | 8,001 | 4,311 | 8,344 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6,634 | 7,179 | 8,001 | 4,311 | 8,344 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.52 | 6.31 | 7.34 | 7.93 | 7.27 |
Dividends per Share |